AMRN Q2 2021 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$154M+14.2% YoY

Gross Profit

$122M79.2% margin

Operating Income

$9M5.7% margin

Net Income

$8M5.1% margin

EPS (Diluted)

$0.40

QoQ Revenue Growth

+8.7%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$400M

Stockholders' Equity

$645M

Cash & Equivalents

$327M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$154M	$135M	+14.2%
Gross Profit	$122M	$107M	+14.8%
Operating Income	$9M	$4M	+111.1%
Net Income	$8M	$4M	+76.9%

Revenue Segments

Product

$154M100%

Licensing And Royalty

$715,0000%